搜索临床试验以:risk calculation
总计15641个结果
-
The Cleveland ClinicNational Cancer Institute (NCI)完全的乳腺癌 | 遗传性乳腺癌/卵巢癌(brca1、brca2)
-
Assaf-Harofeh Medical Center未知
-
Public Health Department, MontrealFonds de la Recherche en Santé du Québec; Ministere de la Sante et des Services Sociaux; Health...未知
-
Rhode Island HospitalCenters for Disease Control and Prevention可用的
-
NYU Langone HealthNational Cancer Institute (NCI)完全的
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)完全的
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)未知乳腺癌 | brca1突变携带者 | brca2突变携带者美国
-
Royal Marsden NHS Foundation Trust未知
-
Abiomed Inc.完全的接受高风险 PCI 的患者。美国, 荷兰
-
Hospital Carlos III, Madrid完全的
-
Catholic University of the Sacred Heart未知
-
United States Department of DefenseGlaxoSmithKline未知
-
Sunnybrook Health Sciences CentreMerck Frosst Canada Ltd.完全的
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Preventive Services and Health Promotion Research Network完全的
-
National Institute of Allergy and Infectious Diseases...Glaxo Wellcome完全的
-
Loughborough UniversityUniversity Hospitals, Leicester未知
-
Geisinger ClinicAgency for Healthcare Research and Quality (AHRQ)完全的
-
Peking Union Medical College Hospital未知
-
Fujirebio Diagnostics, Inc.Advanced Clinical Research Services, LLC; ReSearch Pharmaceutical Services, Inc.完全的
-
Karolinska InstitutetRegion Stockholm; Mälardalen University; City of Stockholm Competence Fund; Lindeparkens upper secondary... 和其他合作者完全的
-
US Department of Veterans Affairs完全的
-
Promyco DiagnosticsSoroka University Medical Center未知
-
Hvidovre University Hospital完全的
-
Memorial Sloan Kettering Cancer Center完全的
-
Benaroya Research InstituteSanofi; Cell Genesys终止
-
University of CopenhagenThe Danish Medical Research Council; Danisco完全的